Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Oct. 30, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.&nb...
read more
In medicine, young women continue to pay a higher price for family

In medicine, young women continue to pay a higher price for family

Forty percent of female doctors in a new study sto...
read more